scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1083783244 |
P356 | DOI | 10.1186/S13041-017-0286-Y |
P932 | PMC publication ID | 5310050 |
P698 | PubMed publication ID | 28196470 |
P50 | author | Haruhisa Inoue | Q88139486 |
Haruhisa Inoue | Q96238987 | ||
P2093 | author name string | Takuya Yamamoto | |
Toshitaka Kawarai | |||
Ryuji Kaji | |||
Yuishin Izumi | |||
Kayoko Tsukita | |||
Naohiro Egawa | |||
Keiko Imamura | |||
Nagahisa Murakami | |||
Takako Enami | |||
P2860 | cites work | Seamless genome editing in human pluripotent stem cells using custom endonuclease-based gene targeting and the piggyBac transposon | Q48925635 |
Brainstem and spinal cord motor neuron involvement with optineurin inclusions in proximal-dominant hereditary motor and sensory neuropathy | Q48952235 | ||
Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. | Q50624483 | ||
Cutadapt removes adapter sequences from high-throughput sequencing reads | Q55953584 | ||
A new type of hereditary motor and sensory neuropathy linked to chromosome 3 | Q73428664 | ||
Impaired proteasome function in Alzheimer's disease | Q73897101 | ||
Hereditary motor and sensory neuropathy (proximal dominant form, HMSN-P) among Brazilians of Japanese ancestry | Q80977720 | ||
Optinurin inclusions in proximal hereditary motor and sensory neuropathy (HMSN-P): familial amyotrophic lateral sclerosis with sensory neuronopathy? | Q84992006 | ||
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions | Q21999527 | ||
Fast gapped-read alignment with Bowtie 2 | Q27860699 | ||
Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
A perspective on stem cell modeling of amyotrophic lateral sclerosis | Q28080614 | ||
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
HTSeq--a Python framework to work with high-throughput sequencing data | Q29614489 | ||
Protein degradation and protection against misfolded or damaged proteins | Q29618400 | ||
Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders | Q30278015 | ||
Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure | Q30538198 | ||
Genetic background drives transcriptional variation in human induced pluripotent stem cells | Q33716774 | ||
Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac | Q34153816 | ||
The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement | Q34293334 | ||
An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells | Q34314350 | ||
Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling | Q34506149 | ||
Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry | Q35177001 | ||
Delivery of full-length factor VIII using a piggyBac transposon vector to correct a mouse model of hemophilia A. | Q35225590 | ||
ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons | Q35802889 | ||
New lessons learned from disease modeling with induced pluripotent stem cells | Q36374130 | ||
iPS cell technologies: significance and applications to CNS regeneration and disease | Q37688424 | ||
Induced pluripotent stem cells: a new revolution for clinical neurology? | Q37857439 | ||
Misfolded PrP and a novel mechanism of proteasome inhibition | Q37997568 | ||
iPS cells: a game changer for future medicine | Q38185513 | ||
TFG-Related Neurologic Disorders: New Insights Into Relationships Between Endoplasmic Reticulum and Neurodegeneration | Q38761524 | ||
TFG clusters COPII-coated transport carriers and promotes early secretory pathway organization | Q38920273 | ||
Evidence of TRK-Fused Gene (TFG1) function in the ubiquitin-proteasome system | Q39016939 | ||
Prion-like properties of pathological TDP-43 aggregates from diseased brains | Q39129644 | ||
Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells | Q39910905 | ||
Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation | Q39910909 | ||
A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells | Q41857309 | ||
Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. | Q41873090 | ||
TFG-1 function in protein secretion and oncogenesis | Q42056487 | ||
Drug screening for ALS using patient-specific induced pluripotent stem cells | Q42820289 | ||
Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process | Q43179672 | ||
Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function | Q44292891 | ||
A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG function | Q48238432 | ||
P433 | issue | 1 | |
P304 | page(s) | 7 | |
P577 | publication date | 2017-02-15 | |
P1433 | published in | Molecular Brain | Q6895938 |
P1476 | title | Proteasome impairment in neural cells derived from HMSN-P patient iPSCs | |
P478 | volume | 10 |
Q38711908 | Editing the genome of hiPSC with CRISPR/Cas9: disease models |
Q52431351 | Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9. |
Q58594046 | Stem Cells, Genome Editing, and the Path to Translational Medicine |
Q55021463 | The natural history of hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) in 97 Japanese patients. |
Q57816866 | Unraveling the Role of Heme in Neurodegeneration |
Search more.